These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 9038418)

  • 41. Beta-peptido sulfonamides: for-Met-Leu-Phe-OMe analogues containing taurine and chiral beta-amino-ethanesulfonic acid residues.
    Giordano C; Nalli M; Paradisi MP; Sansone A; Lucente G; Spisani S
    Farmaco; 2004 Dec; 59(12):953-63. PubMed ID: 15598430
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Studies on fMLP-receptor interaction and signal transduction pathway by means of fMLP-OMe selective analogues.
    Fabbri E; Spisani S; Barbin L; Biondi C; Buzzi M; Traniello S; Zecchini GP; Ferretti ME
    Cell Signal; 2000 Jun; 12(6):391-8. PubMed ID: 10889468
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Crystal structure, conformation, and potential energy calculations of the chemotactic peptide N-formyl-L-Met-L-Leu-L-Phe-OMe.
    Gavuzzo E; Mazza F; Pochetti G; Scatturin A
    Int J Pept Protein Res; 1989 Nov; 34(5):409-15. PubMed ID: 2613442
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Synthesis and biological activity of a conformationally constrained chemotactic gamma-lactam formyl tetrapeptide.
    Cavicchioni G; Breveglieri A; Reali E; Spisani S
    Arzneimittelforschung; 1996 Oct; 46(10):964-6. PubMed ID: 8931889
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Structure-activity relationship of for-L-Met L-Leu-L-Phe-OMe analogues in human neutrophils.
    Cavicchioni G; Fraulini A; Falzarano S; Spisani S
    Bioorg Chem; 2006 Oct; 34(5):298-318. PubMed ID: 16919307
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Synthesis and bioactivity of chemotactic tetrapeptides: fMLF-OMe analogues incorporating spacer aminoacids at the lateral positions.
    Lucente G; Giordano C; Sansone A; Torino D; Spisani S
    Amino Acids; 2009 Jul; 37(2):285-95. PubMed ID: 18636221
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Modified chemotactic peptides: synthesis and activity of an azaTic-containing fMLP-OMe analogue.
    Pagani Zecchini G; Torrini I; Paglialunga Paradisi M; Lucente G; Mastropietro G; Spisani S
    Amino Acids; 1998; 14(4):301-9. PubMed ID: 9871474
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Two for-Met-Leu-Phe-OMe analogues trigger selective neutrophil responses. A differential effect on cytosolic free Ca2+.
    Fabbri E; Spisani S; Biondi C; Barbin L; Colamussi ML; Cariani A; Traniello S; Torrini I; Ferretti ME
    Biochim Biophys Acta; 1997 Dec; 1359(3):233-40. PubMed ID: 9434129
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Synthesis and activity on human neutrophil functions of fMLF-OMe analogs containing alkyl spacers at the central position.
    Pagani Zecchini G; Morera E; Nalli M; Paglialunga Paradisi M; Lucente G; Spisani S
    Farmaco; 2001 Nov; 56(11):851-8. PubMed ID: 11765037
    [TBL] [Abstract][Full Text] [Related]  

  • 50. fMLP-OMe analogs substituted at the methionine residue: an insight into the receptor properties.
    Cavicchioni G; Monesi LG; Ferretti ME; Fabbri E; Rizzuti O; Spisani S
    Arch Pharm (Weinheim); 1998 Nov; 331(11):368-70. PubMed ID: 9881061
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Conformationally constrained formyl methionyl tripeptides: structure-function study of analogs containing alpha,beta-dehydrophenylalanine and dehydroleucine.
    Bharadwaj A; Singh M; Bhandary K; Becker EL; Chauhan VS
    Pept Res; 1993; 6(6):298-307. PubMed ID: 8292847
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Conformationally constrained chemotactic peptide analogs of high biological activity.
    Iqbal M; Balaram P; Showell HJ; Freer RJ; Becker EL
    FEBS Lett; 1984 Jan; 165(2):171-4. PubMed ID: 6692914
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Conformational studies of chemotactic HCO-Met-Leu-Phe-OMe analogues.
    Vertuani G; Boggian M; Breveglieri A; Cavicchioni G; Spisani S; Scatturin A
    Amino Acids; 1995 Dec; 9(4):375-83. PubMed ID: 24178885
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Bioactive fMLF-OMe analogs containing a N-terminal oximic or formylhydrazonic moiety.
    Torrini I; Paglialunga Paradisi M; Pagani Zecchini G; Lucente G; Mastropietro G; Spisani S
    J Pept Res; 2000 Feb; 55(2):102-9. PubMed ID: 10784026
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Biological activity of for-Met-Leu-Phe-OMe analogs: relevant substitutions specifically trigger killing mechanisms in human neutrophils.
    Cavicchioni G; Fraulini A; Turchetti M; Varani K; Falzarano S; Pavan B; Spisani S
    Eur J Pharmacol; 2005 Apr; 512(1):1-8. PubMed ID: 15814083
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Chemotactic peptides: fMLF-OMe analogues incorporating proline-methionine chimeras as N-terminal residue.
    Mollica A; Paradisi MP; Varani K; Spisani S; Lucente G
    Bioorg Med Chem; 2006 Apr; 14(7):2253-65. PubMed ID: 16303307
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Retro-all-D and retro isomers of a formyl-methionyl peptide chemoattractant: an insight into the mode of binding at the receptor on rabbit neutrophils.
    Bonora GM; Toniolo C; Freer RJ; Becker EL
    Biochim Biophys Acta; 1986 Dec; 884(3):545-9. PubMed ID: 3778938
    [TBL] [Abstract][Full Text] [Related]  

  • 58. New chemotactic peptide analogs with high biological activity for human neutrophils.
    Spisani S; Traniello S; Giuliani AL; Torrini I; Pagani Zecchini G; Paglialunga Paradisi M; Gavuzzo E; Mazza F; Pochetti G; Lucente G
    Biochem Int; 1992 May; 26(6):1125-35. PubMed ID: 1321622
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Conformational energy analysis of the chemotactic tripeptide formyl-Met-Leu-Phe and three analogs.
    Feller DC; Zimmerman SS
    Int J Pept Protein Res; 1989 Sep; 34(3):229-34. PubMed ID: 2599761
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Some remarkable effects of thiopeptide and derived linkages on lysozyme release from neutrophils by esters of the chemotactic peptide N-formyl-methionyl-leucyl-phenylalanine (f-Met-Leu-Phe-OR).
    Belleau B; Lajoie G; Sauve G; Rao VS; di Paola A
    Int J Immunopharmacol; 1989; 11(5):467-71. PubMed ID: 2807625
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.